Moderna (MRNA) Inventory Average (2021 - 2026)

Moderna (MRNA) has reported Inventory Average for 6 consecutive years, with $213.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory Average rose 15.76% year-over-year to $213.0 million in Q2 2026; TTM through Jun 2026 was $213.0 million, a 15.76% increase from a year earlier, with the FY2025 full-year figure at $135.0 million, down 15.36% from the prior year.
• Inventory Average was $213.0 million for Q2 2026 at Moderna, up from $149.5 million in the prior quarter.
• Over five years, Inventory Average peaked at $2.0 billion in Q3 2022 and troughed at $122.5 million in Q1 2025.
• A 5-year average of $672.6 million and a median of $345.8 million in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average surged 525.32% in 2022 and plunged 77.23% in 2023, its largest moves.
• Over 5 years, Inventory Average stood at $1.5 billion in 2022, then sank by 77.23% to $344.5 million in 2023, then declined by 23.22% to $264.5 million in 2024, then fell by 8.32% to $242.5 million in 2025, then declined by 12.16% to $213.0 million in 2026.
• The last three Inventory Average figures came in at $213.0 million (Q2 2026), $149.5 million (Q1 2026), and $242.5 million (Q4 2025), per Business Quant data.